Jailendra Singh
Stock Analyst at Truist Securities
(0.93)
# 3,731
Out of 4,876 analysts
174
Total ratings
28.57%
Success rate
-24.52%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HNGE Hinge Health | Initiates: Buy | $48 | $45.00 | +6.67% | 1 | Jun 16, 2025 | |
| PHR Phreesia | Maintains: Buy | $34 → $35 | $28.50 | +22.81% | 6 | May 29, 2025 | |
| TDOC Teladoc Health | Maintains: Hold | $10 → $9 | $8.72 | +3.21% | 16 | May 27, 2025 | |
| DOCS Doximity | Maintains: Hold | $58 → $52 | $61.00 | -14.75% | 8 | May 16, 2025 | |
| WAY Waystar Holding | Maintains: Buy | $45 → $50 | $40.02 | +24.94% | 2 | May 8, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $333 → $300 | $310.40 | -3.35% | 4 | Apr 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $263 → $216 | $157.90 | +36.80% | 15 | Apr 10, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $262 → $208 | $145.57 | +42.89% | 9 | Apr 10, 2025 | |
| PRVA Privia Health Group | Maintains: Buy | $27 → $28 | $21.89 | +27.91% | 7 | Apr 10, 2025 | |
| HIMS Hims & Hers Health | Maintains: Hold | $39 → $33 | $51.02 | -35.32% | 9 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.5 → $5.5 | $4.97 | +10.78% | 12 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $10.80 | +29.63% | 5 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $12 → $7.5 | $7.80 | -3.85% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $46 | $24.60 | +87.03% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $261 → $210 | $283.60 | -25.95% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $26 → $19 | $21.70 | -12.42% | 9 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $13.09 | +6.95% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.4 → $6.5 | $2.29 | +183.84% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $4.23 | +207.33% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $43 | $8.39 | +412.82% | 6 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $3.79 | +534.08% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $2.33 | +71.67% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $166.77 | -65.22% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $5.96 | +654.41% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $728.17 | -54.27% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $2.75 | +227.27% | 2 | May 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $21.72 | - | 3 | Jan 15, 2021 |
Hinge Health
Jun 16, 2025
Initiates: Buy
Price Target: $48
Current: $45.00
Upside: +6.67%
Phreesia
May 29, 2025
Maintains: Buy
Price Target: $34 → $35
Current: $28.50
Upside: +22.81%
Teladoc Health
May 27, 2025
Maintains: Hold
Price Target: $10 → $9
Current: $8.72
Upside: +3.21%
Doximity
May 16, 2025
Maintains: Hold
Price Target: $58 → $52
Current: $61.00
Upside: -14.75%
Waystar Holding
May 8, 2025
Maintains: Buy
Price Target: $45 → $50
Current: $40.02
Upside: +24.94%
Medpace Holdings
Apr 23, 2025
Maintains: Hold
Price Target: $333 → $300
Current: $310.40
Upside: -3.35%
IQVIA Holdings
Apr 10, 2025
Maintains: Buy
Price Target: $263 → $216
Current: $157.90
Upside: +36.80%
ICON Public Limited Company
Apr 10, 2025
Maintains: Buy
Price Target: $262 → $208
Current: $145.57
Upside: +42.89%
Privia Health Group
Apr 10, 2025
Maintains: Buy
Price Target: $27 → $28
Current: $21.89
Upside: +27.91%
Hims & Hers Health
Apr 10, 2025
Maintains: Hold
Price Target: $39 → $33
Current: $51.02
Upside: -35.32%
Apr 10, 2025
Maintains: Hold
Price Target: $6.5 → $5.5
Current: $4.97
Upside: +10.78%
Apr 10, 2025
Maintains: Buy
Price Target: $15 → $14
Current: $10.80
Upside: +29.63%
Apr 10, 2025
Maintains: Hold
Price Target: $12 → $7.5
Current: $7.80
Upside: -3.85%
Mar 18, 2025
Maintains: Buy
Price Target: $50 → $46
Current: $24.60
Upside: +87.03%
Jan 13, 2025
Maintains: Hold
Price Target: $261 → $210
Current: $283.60
Upside: -25.95%
Nov 13, 2024
Downgrades: Hold
Price Target: $26 → $19
Current: $21.70
Upside: -12.42%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $13.09
Upside: +6.95%
May 24, 2024
Maintains: Hold
Price Target: $6.4 → $6.5
Current: $2.29
Upside: +183.84%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $4.23
Upside: +207.33%
Feb 28, 2022
Maintains: Neutral
Price Target: $42 → $43
Current: $8.39
Upside: +412.82%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $3.79
Upside: +534.08%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $2.33
Upside: +71.67%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $166.77
Upside: -65.22%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $5.96
Upside: +654.41%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $728.17
Upside: -54.27%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $2.75
Upside: +227.27%
Jan 15, 2021
Downgrades: Underperform
Price Target: n/a
Current: $21.72
Upside: -